Chicago GYN Oncology Updates

May 14, 2021
Chicago GYN Oncology Updates will celebrate the SGO presidency of Dr. Diane Yamada by providing access to the most important educational and scientific updates for women’s healthcare professionals from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer, including information and resources for members of the entire gynecologic cancer care team who provide treatment and care in the areas of chemotherapy, radiation therapy, and surgery. This highly interactive program will provide participants with distillations of advances in the fields of ovarian cancer and endometrial cancer including both appropriate use of new therapies including immunotherapy, antiangiogenic agents, and PARP inhibitors, and well as information on appropriate use and applications of genomic testing. In addition, the critical importance of clinical research will be highlighted with presentations of Chicago area investigator-initiated trials and information regarding the importance of and suggestions for inclusion of underserved populations in clinical research.

Target Audience

This activity is designed for gynecologic oncologists, medical oncologists, radiation oncologists, gynecologists, trainees, research scientists, nurses, nurse practitioners, physician assistants, and other healthcare professionals dedicated to the care of patients with gynecologic malignancies.

Learning Objectives

At the conclusion of this activity, participants will be able to:
 
  • Define the mechanisms of action & side effect profiles of new gynecologic cancer therapies;
  • Discuss how to apply recent PARP inhibitor research to front-line therapy of ovarian cancer;
  • Describe how to select ovarian cancer patients for maintenance therapy with PARP inhibitors and for antiangiogenic therapy;
  • Identify strategies to explain to patients the efficacy results of immunotherapy and immunotherapy/antiangiogenic combination therapy in endometrial cancer;
  • Determine the sequencing and combination of new agents used for gynecologic cancer care with current therapies;
  • Identify contextual barriers to the integration of new gynecologic cancer agents into patient care;
  • Recall how to overcome barriers to recruit underserved populations for clinical trials;
  • Select appropriate tumor genomic tests for gynecologic cancer patients;
  • Recognize recent advances in the classification and treatment of gynecologic sarcomas.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Polly Rossi
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
219-465-1115
Summary
Available credit: 
  • 3.75 ABIM
Event starts: 
05/14/2021 - 8:00am
Event ends: 
05/14/2021 - 12:30pm
Activity opens: 
05/14/2021
Activity expires: 
08/14/2021
Parent activity set: 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Claiming Credit: Click the "Complete Activity" button to begin.
Please login or create an account to proceed.